Literature DB >> 22733574

Host response signature to Staphylococcus aureus alpha-hemolysin implicates pulmonary Th17 response.

Karen M Frank1, Tong Zhou, Liliana Moreno-Vinasco, Brian Hollett, Joe G N Garcia, Juliane Bubeck Wardenburg.   

Abstract

Staphylococcus aureus pneumonia causes significant morbidity and mortality. Alpha-hemolysin (Hla), a pore-forming cytotoxin of S. aureus, has been identified through animal models of pneumonia as a critical virulence factor that induces lung injury. In spite of considerable molecular knowledge of how this cytotoxin injures the host, the precise host response to Hla in the context of infection remains poorly understood. We employed whole-genome expression profiling of infected lungs to define the host response to wild-type S. aureus compared with the response to an Hla-deficient isogenic mutant in experimental pneumonia. These data provide a complete expression profile at 4 and at 24 h postinfection, revealing a unique response to the toxin-expressing strain. Gene ontogeny analysis revealed significant differences in the extracellular matrix and cardiomyopathy pathways, both of which govern cellular interactions in the tissue microenvironment. Evaluation of individual transcript responses to Hla-secreting staphylococci was notable for upregulation of host cytokine and chemokine genes, including the p19 subunit of interleukin-23. Consistent with this observation, the cellular immune response to infection was characterized by a prominent Th17 response to the wild-type pathogen. These findings define specific host mRNA responses to Hla-producing S. aureus, coupling the pulmonary Th17 response to the secretion of this cytotoxin. Expression profiling to define the host response to a single virulence factor proved to be a valuable tool in identifying pathways for further investigation in S. aureus pneumonia. This approach may be broadly applicable to the study of bacterial toxins, defining host pathways that can be targeted to mitigate toxin-induced disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22733574      PMCID: PMC3418743          DOI: 10.1128/IAI.00191-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  75 in total

1.  Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Taeok Bae; Michael Otto; Frank R Deleo; Olaf Schneewind
Journal:  Nat Med       Date:  2007-12       Impact factor: 53.440

2.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 3.  The role of virulence determinants in community-associated MRSA pathogenesis.

Authors:  Binh An Diep; Michael Otto
Journal:  Trends Microbiol       Date:  2008-06-26       Impact factor: 17.079

4.  Disease-specific gene expression profiling in multiple models of lung disease.

Authors:  Christina C Lewis; Jean Yee Hwa Yang; Xiaozhu Huang; Suman K Banerjee; Michael R Blackburn; Peter Baluk; Donald M McDonald; Timothy S Blackwell; Vijaya Nagabhushanam; Wendy Peters; David Voehringer; David J Erle
Journal:  Am J Respir Crit Care Med       Date:  2007-11-20       Impact factor: 21.405

5.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

6.  Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.

Authors:  Ellen D Renner; Stacey Rylaarsdam; Stephanie Anover-Sombke; Anita L Rack; Janine Reichenbach; John C Carey; Qili Zhu; Annette F Jansson; Julia Barboza; Lena F Schimke; Mark F Leppert; Melissa M Getz; Reinhard A Seger; Harry R Hill; Bernd H Belohradsky; Troy R Torgerson; Hans D Ochs
Journal:  J Allergy Clin Immunol       Date:  2008-07       Impact factor: 10.793

Review 7.  Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review.

Authors:  Z Athanassa; I I Siempos; M E Falagas
Journal:  Eur Respir J       Date:  2008-03       Impact factor: 16.671

8.  Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3.

Authors:  Cindy S Ma; Gary Y J Chew; Nicholas Simpson; Archana Priyadarshi; Melanie Wong; Bodo Grimbacher; David A Fulcher; Stuart G Tangye; Matthew C Cook
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

9.  Vaccine protection against Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Olaf Schneewind
Journal:  J Exp Med       Date:  2008-02-11       Impact factor: 14.307

10.  Identification of a common gene expression response in different lung inflammatory diseases in rodents and macaques.

Authors:  Jeroen L A Pennings; Tjeerd G Kimman; Riny Janssen
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

View more
  26 in total

1.  The impact of α-toxin on host cell plasma membrane permeability and cytokine expression during human blood infection by CA-MRSA USA300.

Authors:  Tyler K Nygaard; Kyler B Pallister; Oliwia W Zurek; Jovanka M Voyich
Journal:  J Leukoc Biol       Date:  2013-09-11       Impact factor: 4.962

Review 2.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

3.  Host Nitric Oxide Disrupts Microbial Cell-to-Cell Communication to Inhibit Staphylococcal Virulence.

Authors:  Rodolfo Urbano; Joyce E Karlinsey; Stephen J Libby; Paschalis-Thomas Doulias; Harry Ischiropoulos; Helen I Warheit-Niemi; Denny H Liggitt; Alexander R Horswill; Ferric C Fang
Journal:  Cell Host Microbe       Date:  2018-05-09       Impact factor: 21.023

4.  Adaptive Immunity Against Staphylococcus aureus.

Authors:  Hatice Karauzum; Sandip K Datta
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 5.  Mouse models for infectious diseases caused by Staphylococcus aureus.

Authors:  Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  J Immunol Methods       Date:  2014-04-24       Impact factor: 2.303

6.  Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.

Authors:  Santiago M Lattar; Mariángeles Noto Llana; Philippe Denoël; Sophie Germain; Fernanda R Buzzola; Jean C Lee; Daniel O Sordelli
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

Review 7.  Pathogenesis of Staphylococcus aureus Bloodstream Infections.

Authors:  Lena Thomer; Olaf Schneewind; Dominique Missiakas
Journal:  Annu Rev Pathol       Date:  2016-02-25       Impact factor: 23.472

8.  TGFBR1 is required for mouse myometrial development.

Authors:  Yang Gao; Kayla J Bayless; Qinglei Li
Journal:  Mol Endocrinol       Date:  2014-02-07

9.  Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells.

Authors:  Thamotharampillai Dileepan; Erica D Smith; Daniel Knowland; Martin Hsu; Maryann Platt; Peter Bittner-Eddy; Brenda Cohen; Peter Southern; Elizabeth Latimer; Earl Harley; Dritan Agalliu; P Patrick Cleary
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

10.  Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia.

Authors:  L Hua; J J Hilliard; Y Shi; C Tkaczyk; L I Cheng; X Yu; V Datta; S Ren; H Feng; R Zinsou; A Keller; T O'Day; Q Du; L Cheng; M Damschroder; G Robbie; J Suzich; C K Stover; B R Sellman
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.